In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...